As of May 29, 2025, cbdMD Inc (YCBD) reports a Gross Margin of 61.57%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of cbdMD Inc's Gross Margin
Over recent years, cbdMD Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-09-30 | 61.57% |
| 2023-09-30 | 62.01% |
| 2022-09-30 | 63.11% |
| 2021-09-30 | 67.42% |
| 2020-09-30 | 62.97% |
This slight upward trend highlights how cbdMD Inc manages its operational efficiency and pricing power over time.
Comparing cbdMD Inc's Gross Margin to Peers
To better understand cbdMD Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| cbdMD Inc (YCBD) | 61.57% |
| Chiasma Inc (CHMA) | 94.59% |
| Strongbridge Biopharma plc (SBBP) | 92.81% |
| Emmaus Life Sciences Inc (EMMA) | 92.79% |
| OptiNose Inc (OPTN) | 90.76% |
| Alimera Sciences Inc (ALIM) | 86.58% |
Compared to its competitors, cbdMD Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.